Veliparib
Veliparib (ABT-888) is a PARP inhibitor being investigated to treat non-small cell lung cancer, BRCA breast cancer and ovarian cancer.
Type of Molecule
Small MoleculeTarget
PARPProduct Type
New IndicationPotential Indication | Region | Phase (1, 2, 3, Submitted) |
---|---|---|
Ovarian Cancer | n/a |
Phase 3
|
Breast Cancer | n/a |
Phase 3
|
Lung Cancer | n/a |
Phase 3
|